516
Views
25
CrossRef citations to date
0
Altmetric
Original Article

Effect of Fructooligosaccharide Containing Enteral Formulas on Subjective Tolerance Factors, Serum Chemistry Profiles, and Faecal Bifidobacteria in Healthy Adult Male Subjects

, , , &
Pages 279-285 | Received 07 Aug 1996, Published online: 11 Jul 2009

References

  • Becker R, Lorenz K, Saunders R M. Saccharides of maturing triticale, wheat and rye. Journal of Agricultural Food Chemistry 1977; 25: 1115–1118
  • Biavati B, Sgorbati B, Scardovi V. The genus bifidobacterium. The Prokaryotes: A Handbook on the Biology of Bacteria2nd edn., A Balows, H G. Triipes, M Dworkin, W Harder, K H. Schleifer. Springer-Verlag. 1992; 816–833
  • Briet F, Achour L, Flourié B, Beaugerie L, Pellier P, Franchisser C, Bornet F, Rambaud J-C. Symptomatic response to varying levels of fructo-oligosaccharides consumed occasionally or regularly. European Journal Clinical Nutrition 1995; 49: 501–507
  • Clevenger M A., Turnbull D, Inoue H, Enomoto M, Allen J, Henderson L, Jones E. Toxicological evaluation of neosugar: Genotoxicity, carcinogenicity, and chronic toxicity. Journal of the American College of Toxicology 1988; 7: 643–662
  • Darbyshire B, Henry R J. Differences in fructan content and synthesis in some Allium species. New Phytologist 1981; 82: 249–256
  • Hata Y, Hara T, Oikawa T, Yamamoto M, Hirose N, Nagashima T, Torihama N, Nakajima K, Watabe A, Yamashita M. Effects of fructooligosaccharides (Neosugar) on hyperlipidemia. Geriatric Medicine 1983; 21: 156–167
  • Hata Y, Nakajima K. Studies on relationship between intake of fructooligosaccharides and abdominal symptoms—Estimation of maximum non-effective dose and 50% laxative effective dose. Geriatric Medicine 1985; 23: 817–828
  • Hidaka H, Eida T, Takizawa T, Tokunaga T, Tashiro Y. Effects of fructooligosaccharides on intestinal flora and human health. Bifidobacteria and Microflora 1986; 5: 37–50
  • Hidaka H, Hirayama M, Yamada K. Fructooligosaccharide enzymatic preparation and biofunction. Journal of Carbohydrate Chemistry 1991; 10: 509–522
  • Homma N. Bifidobacteria as a resistance factor in human beings. Bifidobacteria and Microflora 1988; 7: 35–43
  • Hosoya N, Dhorranintra B, Hidaka H. Utilization of ‘U-14C’ fructooligosaccharides in man as energy resources. Journal of Clinical Biochemistry and Nutrition 1988; 5: 67–74
  • May T, Mackie R I., Fahey G C., Jr, Cremin J C., Garleb K A. Effect of fiber source on short-chain fatty acid production and on the growth and toxin production by Clostridium difficile. Scandinavian Journal of Gastroenterology 1994; 19: 916–922
  • Mitsuoka T. Recent trends in research on intestinal flora. Bifidobacteria and Microflora 1982; 1: 3–24
  • Mitsuoko T, Hidaka H, Eida T. Effect of fructo-oligosaccharides on intestinal microflora. Die Nahrung 1987; 31: 427–436
  • Mitsuoko T, Kaneuchi C. Ecology of the bifidobacteria. American Journal of Clinical Nutrition 1977; 30: 1799–1810
  • Modler H W., McKellar R C., Yaguchi M. Bifidobacteria and bifidogenic factors. Canadian Institute of Food Science and Technology Journal 1990; 23: 29–41
  • Munoa F J., Pares R. Selective medium for isolation and enumeration of Bifidobacterium spp. Applied and Environmental Microbiology 1988; 54: 1715–1718
  • Nash P, Krenz M. Culture media. Manual of Clinical Microbiology5th edn., A Balows. American Society of Microbiology, Washington, DC 1991; 1226–1288
  • Oku T, Tokunaga T, Hosoya N. Non-digestibility of a new sweetener, “Neosugar”, in the rat. Journal of Nutrition 1984; 114: 1574–1581
  • Palmquist D L., Conrad H R. High fat rations for dairy cows. Effects on feed intake, milk and fat production and plasma metabolites. Journal of Dairy Science 1978; 61: 890–901
  • Scardovi V. Bifidobacterium. Bergey's Manual of Systemic Bacteriology1st edn, P H. Sneath, N S. Mair, M E. Sharpe, J Holt. Williams and Wilkins Publishers, Baltimore, MD 1986; Vol II: 1418–1434
  • Shiomi N, Izawa M. Purification and characterization of sucrose-sucrose 1-fructosyl-transferase from the roots of asparagus. Agricultural and Biological Chemistry 1980; 44: 603–614
  • Stone-Dorshow T, Levitt M D. Gaseous response to ingestion of a poorly absorbed fructooligosaccharide sweetener. American Journal of Clinical Nutrition 1987; 46: 61–65
  • Tissier H. Recherches sur la flore intestinale des nourrissons (etat normal et pathologique). 1900, These de medecine de l'Universite de Paris
  • Tokunaga T, Oku T, Hosoya N. Influence of chronic intake of new sweetener fructooligosaccharide (Neosugar) on growth and gastrointestinal function of the rat. Journal of Nutritional Science and Vitaminology 1986; 32: 111–121
  • Tokunaga T, Oku T, Hosoya N. Utilization and excretion of a new sweetener, fructooligosaccharide (Neosugar), in rats. Journal of Nutrition 1989; 119: 553–559
  • Williams C H., Witherly S A., Buddington R K. Influence of dietary neosugar on selected bacterial groups of the human faecal microbiota. Microbial Ecology in Health and Disease 1994; 7: 91–97
  • Wolf B W., Titgemeyer E C., Fahey G C., Garleb K A. Fermentability of selected oligosaccharides. The FASEB Journal 1994; 8: A186